Open access · CC-BY
via OpenAlex
VEGF in Diabetic Retinopathy and Age-Related Macular Degeneration
Andrew Callan, Justin Heckman, Giani Tah, Samantha Lopez, Laura Valdez, Andrew T. C. Tsin
International Journal of Molecular Sciences · 2025 · ▲ 78 citations
Abstract
Vascular endothelial growth factor (VEGF) plays a key role in angiogenesis throughout the human body, influencing countless physiological and pathological processes, including tumor growth, preeclampsia, and retinal diseases such as diabetic retinopathy (DR) and age-related macular degeneration (AMD). In DR, VEGF promotes retinal neovascularization and intraretinal fluid accumulation, leading to complications like diabetic macular edema (DME) and proliferative diabetic retinopathy (PDR). Regular intravitreal anti-VEGF injections are commonly used to manage PDR and DME, though repeated treatments are often required, and efficacy can be limited. AMD, a major cause of vision loss in older adults, is characterized by either dry or wet forms. While the dry form has not been shown to be influenced by VEGF, the choroidal neovascularization of wet AMD has strong associations with VEGF. Current treatment for wet AMD consists primarily of anti-VEGF injections, the gold standard of care, but is limited by varying patient responses, as treatments are often repeated every 4-8 weeks indefinitely. This review explores the pathogenic role of VEGF in both DR and AMD, discussing the molecular mechanisms underlying these diseases and the therapeutic approaches targeting VEGF. Despite advancements, the variability in treatment responses highlights the need for continued research to develop more effective therapies to prevent vision loss and blindness associated with these retinal diseases.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/ijms26114992
- Canonical
- link ↗
- Fetched
- 2026-11-13 MST
Cite this
APA
Callan, A., Heckman, J., Tah, G., Lopez, S., Valdez, L., & Tsin, A.T.C. (2025). VEGF in Diabetic Retinopathy and Age-Related Macular Degeneration. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms26114992
Vancouver
Callan A, Heckman J, Tah G, Lopez S, Valdez L, Tsin ATC. VEGF in Diabetic Retinopathy and Age-Related Macular Degeneration. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26114992.
BibTeX
@article{andrew2025VEGFin,
title = {VEGF in Diabetic Retinopathy and Age-Related Macular Degeneration},
author = {Andrew Callan and Justin Heckman and Giani Tah and Samantha Lopez and Laura Valdez and Andrew T. C. Tsin},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26114992},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Developments in ophthalmology 2015
Citation only
Neovascular Age-Related Macular Degeneration
JAMA 2024
Preprint · OA
Age-Related Macular Degeneration
Zhonghua shiyan yanke zazhi 2019
Citation only
The research status and the limitations of mesenchymal stem cell-based therapies in age-related macular degeneration
Genaera Corporation 2004
Open access · US-GOV
A Safety and Efficacy Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular Degeneration
Oxidative Medicine and Cellular Longevity 2018
Open access · CC-BY
Age‐Related Macular Degeneration: New Paradigms for Treatment and Management of AMD
Workplace Health & Safety 2014
Citation only